AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Savara Inc Director's Dealing 2017

May 8, 2017

32709_dirs_2017-05-08_4e22d5a6-7ab6-4cd5-8fa2-83ab2bfcad58.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Savara Inc (SVRA)
CIK: 0001160308
Period of Report: 2017-04-27

Reporting Person: Serenova a/s (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1965400	Direct

Footnotes

F1: Includes 393,080 shares held in escrow by Savara Inc. until July 19, 2017 pursuant to the terms of the Business Transfer Agreement dated May 13, 2016 between Serendex Pharmaceuticals A/S and Savara Inc.